The proliferation status of PASMCs was first measured in situ by proliferating cell nuclear antigen (PCNA)-immunodetection in lung tissues from control and IPAH patients (Figure 1A). The gene discussed is PCNA; the disease is idiopathic pulmonary arterial hypertension.